European Archives - Page 253 of 1124 - European Medical Journal

Lower Risk of Colorectal Cancer with Aspirin Use in People with Unhealthy Lifestyles

Research highlights that aspirin use is associated with a significant reduction in colorectal cancer incidence, particularly among individuals with less healthy lifestyle habits.

New Biomarkers Predict Disease Activity in Juvenile Arthritis

Researchers have identified two new potential biomarkers, which could be crucial in predicting disease activity in children with non-systemic juvenile idiopathic arthritis.

EMJ Hematology 12 [Supplement 3] 2024

Find out more about the current management and patient experience of warm autoimmune haemolytic anaemia (wAIHA)…

FDA nod for world's first needle-free allergic reaction treatment

The FDA has granted approval for an innovative epinephrine nasal spray, making it the first needle-free emergency treatment for potentially fatal allergic reactions.

Upgrading the US congress customer experience

A US congress is the place to put your drug on the map, but is this landscape the home of great customer experience for HCPs?

Astellas’ Tadaaki Taniguchi on how to challenge the status quo

In this season finale of the podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma.

Stress Diminishes Cognitive Reserve's Protective Role in Dementia

Recent research from the Karolinska Institutet in Stockholm has shed light on the complex relationship between cognitive reserve and stress.

Myotonia: Are We Underestimating the Burden in Myotonic Disorders?

‘Raising awareness of the burden of disease due to myotonia will enhance understanding of patients’ needs, and improve the management…

EMJ Neurology 12.1 2024

A feature calling for a biological definition for Parkinson’s disease, and an article highlighting the importance of early recognition…

Interview: Tom Davenport

For clinical applications of AI, it’s still early; most are unlikely to be found at the patient’s bedside and are still in the research…